M&A Deal Summary

Bausch Health Acquires Aton Pharma

On May 28, 2010, Bausch Health acquired life science company Aton Pharma from Aisling Capital and Spring Mountain Capital for 318M USD

Acquisition Highlights
  • This is Bausch Health’s 5th transaction in the Life Science sector.
  • This is Bausch Health’s 13th largest (disclosed) transaction.
  • This is Bausch Health’s 4th transaction in the United States.
  • This is Bausch Health’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2010-05-28
Target Aton Pharma
Sector Life Science
Buyer(s) Bausch Health
Sellers(s) Aisling Capital
Spring Mountain Capital
Deal Type Add-on Acquisition
Deal Value 318M USD

Target

Aton Pharma

Lawrenceville, New Jersey, United States
Aton Pharma, Inc. is a specialty pharmaceutical company providing unique medicines to patients around the world.With 11 products on the market, 8 in the pipeline, and sales in over 30 countries, we are a global leader in providing medically essential treatments for serious and potentially life-threatening medical conditions. Our products address 2 areas — ophthalmic and orphan drug (rare disease) markets.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada
Category Company
Sector Life Science
Employees20,270
Revenue 8.8B USD (2023)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.

DEAL STATS #
Overall 6 of 35
Sector (Life Science) 5 of 21
Type (Add-on Acquisition) 6 of 25
State (New Jersey) 1 of 5
Country (United States) 4 of 22
Year (2010) 2 of 4
Size (of disclosed) 13 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-28 VitalScience

Toronto, Ontario, Canada

VitalScience Corp. is a over-the-counter (OTC) dermatology company located in Toronto, Ontario. VitalScience is an independent Canadian corporation dedicated to providing innovative, effective, unique, products and services to the Canadian market.

Buy CA$11M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-06-21 Biovail

Quebec, Canada

Biovail Corp. is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets.

Buy -

Seller(S) 2

SELLER

Aisling Capital

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 1.8B USD
Size Large
Type Sector Focused
DESCRIPTION

Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.

DEAL STATS #
Overall 14 of 41
Sector (Life Science) 12 of 32
Type (Add-on Acquisition) 13 of 24
State (New Jersey) 3 of 6
Country (United States) 14 of 41
Year (2010) 3 of 3
Size (of disclosed) 8 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-22 Aragon Pharmaceuticals

San Diego, California, United States

Aragon Pharmaceuticals is a privately held, small-molecule drug discovery company focused on developing breakthrough medicines for the treatment of hormonally-driven cancers.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-01 Archimica

Origgio, Virginia, United States

Archimica is a privately held pharmaceutical fine chemical company that combines world-scale chemical manufacturing experience with a history of pharmaceutical commercialization that stretches back over 40 years.

Sell -
SELLER

Spring Mountain Capital

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2001
Size Small
Type Sector Agnostic
DESCRIPTION

Spring Mountain Capital is a growth capital firm focused on providing expansion capital to tech-enabled companies across North America. The Firm looks to invest in earlier stage companies ($2 to $10 million of revenue) with high growth rates, proven products/services, and a path to profitability. Spring Mountain generally looks to commit $5 to $15 million per transaction. Spring Mountain Capital was formed in 2001 and is based in New York City.

DEAL STATS #
Overall 2 of 20
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 2 of 18
State (New Jersey) 1 of 4
Country (United States) 2 of 20
Year (2010) 1 of 2
Size (of disclosed) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-09-29 Applied Genetics

Freeport, New York, United States

Applied Genetics Incorporated Dermatics is a bio-pharmaceutical company that develops and sells high-end skincare products and cosmetic ingredients.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-07-01 BHS Specialty Chemicals

Salt Lake City, Utah, United States

BHS Specialty Chemicals LLC (formerly BHS Marketing LLC) is a manufacturer, blender and distributor of specialty chemicals with facilities in Salt Lake City, UT, Nampa, ID and Fort Lupton, CO. BHS primarily serves the food processing and water treatment industries.

Buy -
Mergr

Product

Company

Legal